| 1501 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
69 |
| 1502 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
70 |
| 1503 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
75 |
| 1504 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
56 |
| 1505 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
23 |
| 1506 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
54 |
| 1507 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
69 |
| 1508 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
70 |
| 1509 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
65 |
| 1510 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
48 |
| 1511 |
Bone Marrow Family |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Germany
|
72 |
| 1512 |
Bone Marrow Family |
Allogeneic
|
Chronic Lymphocytic Leukemia Richter Transformation
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
55 |
| 1513 |
Bone Marrow Family |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
63 |
| 1514 |
Bone Marrow Family |
Allogeneic
|
Follicular Lymphoma
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
48 |
| 1515 |
Bone Marrow Family |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
65 |
| 1516 |
Bone Marrow Family |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2024
|
Standard Therapy
|
Germany
|
58 |
| 1517 |
Bone Marrow Family |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
70 |
| 1518 |
Bone Marrow Family |
Allogeneic
|
Myelodysplastic Syndrome – Refractory Cytopenia Of Childhood
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
14 |
| 1519 |
Bone Marrow Family |
Allogeneic
|
Myelodysplastic Syndrome/ Myeloproliferative Neoplasms
|
Hematology
|
2024
|
Standard Therapy
|
Germany
|
61 |
| 1520 |
Bone Marrow Family |
Allogeneic
|
Myelodysplastic Syndrome-MPN
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
71 |
| 1521 |
Bone Marrow Family |
Allogeneic
|
Myelofibrosis
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
68 |
| 1522 |
Bone Marrow Family |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
64 |
| 1523 |
Bone Marrow Family |
Allogeneic
|
Polycythemia Vera/Myelofibrosis
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
74 |
| 1524 |
Bone Marrow Family |
Allogeneic
|
Primary Myelofibrosis
|
Hematology
|
2024
|
Standard Therapy
|
Germany
|
62 |
| 1525 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
68 |
| 1526 |
Bone Marrow Family |
Allogeneic
|
Myelodysplasia
|
Hematology
|
2024
|
Standard Therapy
|
United Kingdom
|
57 |
| 1527 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Germany
|
69 |
| 1528 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
USA
|
58 |
| 1529 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
USA
|
60 |
| 1530 |
Bone Marrow Family |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
71 |
| 1531 |
Bone Marrow Family |
Allogeneic
|
High risk Myelodysplastic Syndrome
|
Hematology
|
2024
|
Standard Therapy
|
Germany
|
69 |
| 1532 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
USA
|
74 |
| 1533 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
15 |
| 1534 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
8 |
| 1535 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
12 |
| 1536 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
8 |
| 1537 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
52 |
| 1538 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
57 |
| 1539 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
66 |
| 1540 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
5 |
| 1541 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
54 |
| 1542 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
56 |
| 1543 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
3 |
| 1544 |
Bone Marrow |
Allogeneic
|
Adrenoleukodystrophy
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
7 |
| 1545 |
Bone Marrow |
Allogeneic
|
Adrenoleukodystrophy
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
7 |
| 1546 |
Bone Marrow |
Allogeneic
|
Adrenoleukodystrophy
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
9 |
| 1547 |
Bone Marrow |
Allogeneic
|
B-Acute Lymphoblastic Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
7 |
| 1548 |
Bone Marrow |
Allogeneic
|
Chronic Granulomatous Disease
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
4 |
| 1549 |
Bone Marrow |
Allogeneic
|
Chronic Granulomatous Disease
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
41 |
| 1550 |
Bone Marrow |
Allogeneic
|
Chronic Lymphocytic Leukemia Richter Transformation
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
55 |
| 1551 |
Bone Marrow |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
67 |
| 1552 |
Bone Marrow |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
12 |
| 1553 |
Bone Marrow |
Allogeneic
|
Diffuse Large B-Cell Lymphoma
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
61 |
| 1554 |
Bone Marrow |
Allogeneic
|
Genetically Determined Thrombocytopenia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
4 |
| 1555 |
Bone Marrow |
Allogeneic
|
High Risk Acute Myeloid Leukaemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
13 |
| 1556 |
Bone Marrow |
Allogeneic
|
Hodgkin Lymphoma
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
32 |
| 1557 |
Bone Marrow |
Allogeneic
|
Inherited Metabolic Disease
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
11 |
| 1558 |
Bone Marrow |
Allogeneic
|
Mds-Rcc Relapse
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
14 |
| 1559 |
Bone Marrow |
Allogeneic
|
Mixed Cellularity Hodgkin Lymphoma
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
43 |
| 1560 |
Bone Marrow |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
14 |
| 1561 |
Bone Marrow |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
8 |
| 1562 |
Bone Marrow |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
14 |
| 1563 |
Bone Marrow |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
67 |
| 1564 |
Bone Marrow |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
9 |
| 1565 |
Bone Marrow |
Allogeneic
|
Osteopetrosis type B
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
13 |
| 1566 |
Bone Marrow |
Allogeneic
|
Other Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
9 |
| 1567 |
Bone Marrow |
Allogeneic
|
Primary Immunodeficiency
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
7 |
| 1568 |
Bone Marrow |
Allogeneic
|
Primary Immunodeficiency Xlp-1
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
18 |
| 1569 |
Bone Marrow |
Allogeneic
|
Relapse T-Acute Lymphoblastic Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
12 |
| 1570 |
Bone Marrow |
Allogeneic
|
Secondary Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
4 |
| 1571 |
Bone Marrow |
Allogeneic
|
Secondary Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
15 |
| 1572 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
7 |
| 1573 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
3 |
| 1574 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
10 |
| 1575 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
21 |
| 1576 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
18 |
| 1577 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
49 |
| 1578 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
16 |
| 1579 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
24 |
| 1580 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
13 |
| 1581 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
14 |
| 1582 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
21 |
| 1583 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
7 |
| 1584 |
Bone Marrow |
Allogeneic
|
Severe Combined Immunodeficiency
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
2 |
| 1585 |
Bone Marrow |
Allogeneic
|
Severe Congenital Neutropenia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
1 |
| 1586 |
Bone Marrow |
Allogeneic
|
Shwachman-Diamond Syndrome
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
10 |
| 1587 |
Bone Marrow |
Allogeneic
|
Sickle Cell Disease
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
9 |
| 1588 |
Bone Marrow |
Allogeneic
|
Biphenotypic Acute Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Ukraine
|
10 |
| 1589 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
58 |
| 1590 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
United Kingdom
|
12 |
| 1591 |
Bone Marrow |
Allogeneic
|
hemophagocytic lymphohistiocytosis
|
Hematology
|
2024
|
Standard Therapy
|
Sweden
|
4 |
| 1592 |
Bone Marrow |
Allogeneic
|
Severe combined immunodeficiency
|
Hematology
|
2024
|
Standard Therapy
|
Germany
|
1 |
| 1593 |
Bone Marrow |
Allogeneic
|
Beta-Thalassemia Major
|
Hematology
|
2024
|
Standard Therapy
|
India
|
11 |
| 1594 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Austria
|
4 |
| 1595 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Norway
|
33 |
| 1596 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Spain
|
16 |
| 1597 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2024
|
Standard Therapy
|
Switzerland
|
5 |
| 1598 |
Bone Marrow |
Allogeneic
|
T- Acute Lymphoblastic Leukemia
|
Hematology
|
2024
|
Standard Therapy
|
Ireland
|
6 |
| 1599 |
Bone Marrow |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2024
|
Standard Therapy
|
Poland
|
12 |
| 1600 |
Bone Marrow |
Allogeneic
|
Severe Combined Immunodeficiency
|
Hematology
|
2024
|
Standard Therapy
|
USA
|
4 |